According to publicly disclosed information, Conflux's two founders, Long Fan and Wu Ming, are both executive directors of the Hong Kong-listed company, Leadingpharm Health Technology.

Currently, Leadingpharm Health Technology has a total market cap of HK$371 million, equivalent to approximately $47.26 million USD. The total market cap of the Conflux (CFX) token is $393.00 million USD, currently ranked 138th in the cryptocurrency market cap rankings.
<img src="https://static.sosovalue.com/sosovalue/2025/07/01/c07872eb-6de9-4f63-b3b2-aa97703e5719.png"/>

Leading Nation Pharma Proposes to Acquire All Equity of Conflux, Both Parties Have Entered into a Memorandum of Understanding

Hong Kong-listed Leading Nation Pharmaceutical & Biotechnology (00399) issued an announcement stating that on June 30, 2025, the company (as the buyer) has entered into a memorandum of understanding with the seller (Northwestern Foundation) and Conflux regarding the potential acquisition of all equity in the target company, conditional upon the target company completing the acquisition of Conflux assets in accordance with the agreement with the company.

Conflux is a limited company incorporated in Hong Kong, China, primarily engaged in the development of blockchain technology. The target company is a limited company to be incorporated in the Cayman Islands by the seller and wholly owned by the seller. The company is actively exploring new business opportunities to diversify its sources of income and implement strategic plans to improve performance, and the company intends to expand its business to blockchain technology and enter the digital innovation industry.